Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for ALKS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 1.485B
March 31, 2026 -1.500B
December 31, 2025 19.85M
September 30, 2025 -0.622M
June 30, 2025 -2.083M
March 31, 2025 -29.53M
December 31, 2024 -7.873M
September 30, 2024 110.36M
June 30, 2024 82.73M
March 31, 2024 17.12M
December 31, 2023 0.747M
September 30, 2023 -2.317M
June 30, 2023 -8.586M
March 31, 2023 21.87M
December 31, 2022 -0.479M
September 30, 2022 -0.538M
June 30, 2022 -15.68M
March 31, 2022 15.27M
December 31, 2021 2.429M
September 30, 2021 -1.799M
June 30, 2021 -17.74M
March 31, 2021 8.36M
December 31, 2020 -0.56M
September 30, 2020 -0.599M
June 30, 2020 -3.726M
Date Value
March 31, 2020 4.213M
December 31, 2019 -2.457M
September 30, 2019 -3.617M
June 30, 2019 -1.86M
March 31, 2019 -1.674M
December 31, 2018 1.278M
September 30, 2018 -1.275M
June 30, 2018 -3.818M
March 31, 2018 2.56M
December 31, 2017 -5.204M
September 30, 2017 -1.893M
June 30, 2017 -6.021M
March 31, 2017 6.034M
December 31, 2016 -2.527M
September 30, 2016 -5.256M
June 30, 2016 1.143M
March 31, 2016 -0.201M
December 31, 2015 -4.497M
September 30, 2015 -9.763M
June 30, 2015 4.10M
March 31, 2015 -8.905M
December 31, 2014 -19.87M
September 30, 2014 -5.59M
June 30, 2014 1.753M
March 31, 2014 -259.43M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Amarin Corp. Plc -0.059M
Jazz Pharmaceuticals Plc -22.70M
Prothena Corp. Plc 15.50M
ACADIA Pharmaceuticals, Inc. -10.49M
Biogen, Inc. -6.00M